Literature DB >> 21369745

Glucocorticoid treatment, immobility, and constipation are associated with nutritional risk.

Jean-Pierre Gutzwiller1, Josef Aschwanden, Samuel Iff, Michèle Leuenberger, Martin Perrig, Zeno Stanga.   

Abstract

PURPOSE: The hypothesis of this clinical study was to determine whether glucocorticoid use and immobility were associated with in-hospital nutritional risk.
METHODS: One hundred and one patients consecutively admitted to the medical wards were enrolled. Current medical conditions, symptoms, medical history, eating and drinking habits, diagnosis, laboratory findings, medications, and anthropometrics were recorded. The Nutrition Risk Score 2002 (NRS-2002) was used as a screening instrument to identify nutritional risk.
RESULTS: The results confirmed that glucocorticoid use and immobility are independently associated with nutritional risk determined by the NRS-2002. Constipation could be determined as an additional cofactor independently associated with nutritional risk.
CONCLUSIONS: Glucocorticoid treatment, immobility, and constipation are associated with nutritional risk in a mixed hospitalized population. The presence of long-time glucocorticoid use, immobility, or constipation should alert the clinician to check for nutritional status, which is an important factor in mortality and morbidity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21369745     DOI: 10.1007/s00394-011-0177-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  29 in total

1.  ESPEN guidelines for nutrition screening 2002.

Authors:  J Kondrup; S P Allison; M Elia; B Vellas; M Plauth
Journal:  Clin Nutr       Date:  2003-08       Impact factor: 7.324

2.  Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission.

Authors:  B J Geerling; A Badart-Smook; R W Stockbrügger; R J Brummer
Journal:  Am J Clin Nutr       Date:  1998-05       Impact factor: 7.045

3.  EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome.

Authors:  Janice Sorensen; Jens Kondrup; Jacek Prokopowicz; Marc Schiesser; Lukas Krähenbühl; Rémy Meier; Martin Liberda
Journal:  Clin Nutr       Date:  2008-05-27       Impact factor: 7.324

4.  Loss of body cell mass in Cushing's syndrome: effect of treatment.

Authors:  Matthias Pirlich; Henrik Biering; Helga Gerl; Manfred Ventz; Bernd Schmidt; Siegfried Ertl; Herbert Lochs
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

5.  Progressive changes in serum cortisol, insulin and growth hormone concentrations and their relationship to the distorted amino acid pattern during the development of kwashiorkor.

Authors:  P G Lunn; R G Whitehead; R W Hay; B A Baker
Journal:  Br J Nutr       Date:  1973-05       Impact factor: 3.718

Review 6.  Myths and misconceptions about chronic constipation.

Authors:  Stefan A Müller-Lissner; Michael A Kamm; Carmelo Scarpignato; Arnold Wald
Journal:  Am J Gastroenterol       Date:  2005-01       Impact factor: 10.864

7.  Predictors of clinical response to systemic steroids in active ulcerative colitis.

Authors:  Isabel Bernal; Míriam Mañosa; Eugeni Domènech; Esther Garcia-Planella; Mercè Navarro; Vicente Lorenzo-Zúñiga; Eduard Cabré; Miquel Angel Gassull
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

8.  Sarcopenia and frailty in geriatric patients: implications for training and prevention.

Authors:  W Mühlberg; C Sieber
Journal:  Z Gerontol Geriatr       Date:  2004-02       Impact factor: 1.281

9.  The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass.

Authors:  A M Roza; H M Shizgal
Journal:  Am J Clin Nutr       Date:  1984-07       Impact factor: 7.045

10.  New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.

Authors:  S Ewig; N Birkner; R Strauss; E Schaefer; J Pauletzki; H Bischoff; P Schraeder; T Welte; G Hoeffken
Journal:  Thorax       Date:  2009-05-18       Impact factor: 9.139

View more
  1 in total

1.  Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study.

Authors:  Daigo Kamei; Yuiko Kamei; Masashi Nagano; Michio Mineshima; Kosaku Nitta; Ken Tsuchiya
Journal:  BMC Gastroenterol       Date:  2020-01-31       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.